Multidrug-resistant tuberculosis. [PDF]
, 2008 BACKGROUND: With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of ...
Zager, Ellen M +3 more
core +1 more source
Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan
Emerging Infectious Diseases, 2010 The emergence and spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has raised public health concern about global control of TB.
Yoshiro Murase +7 more
doaj +1 more source
Assessment of Comorbidity in Patients with Drug-Resistant Tuberculosis
Pathogens, 2023 A wide range of comorbidities, especially in multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) patients, markedly complicates selecting effective treatment of tuberculosis (TB) and preventing the development ...
Anna Starshinova +5 more
doaj +1 more source
Extensively drug resistant tuberculosis in South Africa [PDF]
, 2011 Includes abstract.Includes bibliographical references (leaves 161-168).There are few data for treatment-related outcomes in patients with XDR tuberculosis in settings with high HIV prevalence.
Shean, Karen Penelope
core +1 more source
Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. [PDF]
, 2012 Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB).
Varghese, B +51 more
core +1 more source
Profil Pasien TB PRE-XDR dan TB-XDR di RSUP H Adam Malik Medan [PDF]
, 2022 Background: Pre-XDR-TB and XDR-TB are one of the health problems in Indonesia. The low treatment rates and treatment success rates, as well as high mortality rates need serious attention.
S., Herison Efrata
core
Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation. [PDF]
PLoS ONE, 2013 BACKGROUND: The treatment of patients with MDR- and XDR-TB is usually more complex, toxic and costly and less effective than treatment of other forms of TB. However, there is little information available on risk factors for poor outcomes in patients with
Shenjie Tang +12 more
doaj +1 more source
Factors Related to Pre-XDR-TB and XDR-TB at H Adam Malik General Hospital Medan
, 2022 Background: Pre-XDR-TB and XDR-TB are still one of the health problems in Indonesia. Treatment rates and treatment success rate are quite low, as well as high mortality rates that need serious attention. Therefore, it is necessary to find out the factors
S, Herison Efrata
core +1 more source
Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China
BMC Infectious Diseases, 2017 Background Extensively Drug-Resistant (XDR) Tuberculosis (TB) has posed a great threat to global health and finance systems, especially for developing countries with high TB and Multidrug-Resistant (MDR) TB burden. Methods We retrospectively analyzed HIV-
Xiao-chun He +4 more
doaj +1 more source
International Journal of Mycobacteriology, 2016 Objective/Background: Tuberculosis (TB) is a leading cause of death worldwide, with new threats of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB.
Hasnain Javed +3 more
doaj +1 more source